MBX BIOSCIENCES INC (MBX) Forecast, Price Target & Analyst Ratings

NASDAQ:MBX • US55287L1017

Current stock price

28.68 USD
+0.25 (+0.88%)
At close:
28.68 USD
0 (0%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MBX BIOSCIENCES INC (MBX).

Forecast Snapshot

Consensus Price Target

Price Target
$62.32
+ 117.30% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.58
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$62.32
Upside
+ 117.30%
From current price of $28.68 to mean target of $62.32, Based on 15 analyst forecasts
Low
$18.18
Median
$64.26
High
$92.40

Price Target Revisions

1 Month
0.00%
3 Months
4.22%

Price Target Summary

15 Wall Street analysts provided a forecast for the next 12 months for MBX. The average price target is 62.32 USD. This implies a price increase of 117.3% is expected in the next year compared to the current price of 28.68.
The average price target has been revised upward by 4.22% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

MBX Current Analyst RatingMBX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6

Analyst Ratings History

MBX Historical Analyst RatingsMBX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -16 -14 -12 -10 -8 -6 -4 -2 0 5 10

Analyst Ratings Consensus

ChartMill Buy Consensus
82.67%
MBX was analyzed by 15 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about MBX.
In the previous month the buy percentage consensus was at a similar level.
MBX was analyzed by 15 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-01-28BarclaysInitiate Overweight
2026-01-16GuggenheimMaintains Buy -> Buy
2026-01-07UBSInitiate Buy
2025-12-19StifelMaintains Buy -> Buy
2025-12-04Goldman SachsInitiate Sell
2025-11-10GuggenheimMaintains Buy -> Buy
2025-11-04TD CowenInitiate Buy
2025-10-15Truist SecuritiesInitiate Buy
2025-09-24MizuhoMaintains Outperform -> Outperform
2025-09-23GuggenheimMaintains Buy -> Buy
2025-09-23OppenheimerMaintains Outperform -> Outperform
2025-08-05MizuhoInitiate Outperform
2025-07-16OppenheimerInitiate Outperform
2025-04-10GuggenheimReiterate Buy -> Buy
2025-04-10JMP SecuritiesInitiate Market Outperform
2024-10-08GuggenheimInitiate Buy
2024-10-08StifelInitiate Buy
2024-10-08JP MorganInitiate Overweight
2024-10-08JefferiesInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q1 / 2026
EPS Estimate
-$0.58
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
17.85%
Number of Analysts
11

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
19.38%
EPS (3 Months)
21.28%

Next Earnings Summary

MBX is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.58 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
MBX revenue by date.MBX revenue by date.
N/AN/AN/AN/A
3,030.27%		N/A
80.75%		N/A
124.74%		N/A
66.50%		N/A
44.55%
EBITDA
YoY % growth
MBX ebitda by date.MBX ebitda by date.
-25.105M-35.154M
-40.03%		-67.95M
-93.29%		-97.807M
-43.94%		N/A
-35.03%		N/A
-18.72%		N/A
7.47%		N/A
-37.55%		N/A
39.45%		N/A
235.20%		N/A
330.01%		N/A
92.31%
EBIT
YoY % growth
MBX ebit by date.MBX ebit by date.
-25.161M-35.311M
-40.34%		-68.194M
-93.12%		-98.055M
-43.79%		N/A
-55.00%		N/A
-46.69%		N/A
-16.55%		N/A
41.96%		N/A
48.78%		N/A
303.46%		N/A
200.59%		N/A
76.34%
Operating Margin
MBX operating margin by date.MBX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
MBX eps by date.MBX eps by date.
N/AN/AN/A-2.41
79.16%		N/A
-25.24%		N/A
-27.05%		N/A
10.61%		N/A
3.89%		N/A
79.77%		N/A
566.67%		N/A
127.60%		N/A
57.99%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.58
17.85%		-0.84
-44.07%		-0.88
-39.26%		-0.95
-94.13%		-1.09
-87.71%		-1.21
-44.92%		-1.33
-51.04%		-1.44
-51.52%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-30.848M
-16.62%		-42.074M
-94.18%		-41.075M
-73.03%		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-33.149M
-24.95%		-41.307M
-89.44%		-42.93M
-79.43%		-47.874M
-85.59%		N/AN/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

MBX Yearly Revenue VS EstimatesMBX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 2030 2031 2032 2033 500M 1B
MBX Yearly EPS VS EstimatesMBX Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-12.46%
EPS Next 5 Year
11.50%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
-11.19%
EBIT Next 5 Year
-2.74%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

MBX BIOSCIENCES INC / MBX Forecast FAQ

What is the average price target for MBX BIOSCIENCES INC (MBX) stock?

15 analysts have analysed MBX and the average price target is 62.32 USD. This implies a price increase of 117.3% is expected in the next year compared to the current price of 28.68.

When does MBX BIOSCIENCES INC (MBX) report earnings?

MBX BIOSCIENCES INC (MBX) will report earnings on 2026-05-11.

What are the consensus estimates for MBX stock next earnings?

The consensus EPS estimate for the next earnings of MBX BIOSCIENCES INC (MBX) is -0.58 USD and the consensus revenue estimate is 0 USD.

How many analysts cover MBX BIOSCIENCES INC (MBX) stock?

The number of analysts covering MBX BIOSCIENCES INC (MBX) is 15.